BioCryst Pharmaceuticals, Inc.

There are pivotal moments that stick in the mind of any longtime CEO. Some are good, some are bad, all are memorable. For Bill Burns, three defining snapshots encapsulate the highs and lows of his nin

There are pivotal moments that stick in the mind of any longtime CEO. Some are good, some are bad, all are memorable. For Bill Burns, three defining snapshots encapsulate the highs and lows of his nin

Ionis has brought products to market under partnerships – namely Biogen’s spinal muscular atrophy drug Spinraza (nusinersen) and the recently launched transthyretin amyloidosis drug Wainua (eplonterse

Pharvaris NV is seeking to improve upon the standard-of-care for both treatment and prevention of hereditary angioedema (HAE) with its oral bradykinin B2 receptor antagonist deucrictibant, announcing